Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia

Pediatric Reports

Volumn 3, Issue 1, 2011, Pages

  Giurici, Nagua ^a   Zanazzo, Giulio A ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Antibiotic therapy; Neutropenia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CIPROFLOXACIN; GLYCOPEPTIDE; OFLOXACIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD CULTURE; BLOOD SAMPLING; BONE INFECTION; CATHETER INFECTION; CHILD HEALTH CARE; CLINICAL EFFECTIVENESS; COMBINATION CHEMOTHERAPY; COMMUNICABLE DISEASE; CONSENSUS DEVELOPMENT; DIAGNOSTIC VALUE; DRUG INDICATION; FEBRILE NEUTROPENIA; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HIGH RISK POPULATION; HUMAN; INFECTIOUS ARTHRITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOTHERAPY; NEUTROPHIL COUNT; NONHUMAN; PRACTICE GUIDELINE; PSEUDOMONAS INFECTION; SEPSIS; SKIN INFECTION; SOFT TISSUE INFECTION; TREATMENT WITHDRAWAL;

EID: 83655191726     PISSN: None     EISSN: 20367503     Source Type: Journal    
DOI: 10.4081/pr.2011.e4     Document Type: Article

References (18)

1. Agaoglu L, Devecioglu O, Anak S, et al. Cost effectiveness of cefepime+netilmicin or ceftazidime+amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Tukey. J Chemother 2001;13:281-7.
2. Corapcioglu F, Sarper N. Cefepime versus ceftazidime+amikacin as empirical therapy for febrile neutropenia inc hildren with cancer: a prospective randomized trial of the treatment efficacy and cost. J Pediatr Hematol Oncol 2005;22:59-70.
3. Pereira CA, Petrilli AS, Carlesse FA, et al. Cefepime monotherapy is as effective as cetriaxone plus amikacin in pediatric patient with caner and high-risk febrile neutropenia in a randomized comparison. J Microbiol Immunol Infect 2009;42:141-7.
4. Klastersky J. Why empirical therapy? J Antimicrob Chemother 2009;63:i14-15.
5. Pizzo PA. Where do we go from here? J Antimicrob Chemother 2009;63:i16-17.
6. Santolaya ME Supportive care in children. Curr Opin Oncol 2010;22:323-9.
7. Paul M, Borok S, Fraser A, et al. Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients. Cochrane Database Syst Rev 2005;CD00 3914.
8. Vardakas K, Samonis G, Chrysanthopoulou SA, et al. Role of glycopeptides as part of initial treatment of febrile neutropenic patients: a meta analysis of randomized controlled trials. Lancet Infect Dis 2005;5: 431-9.
9. Paul M, Borok S, Fraser A, et al. Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2005;55:436-44.
10. Gupta A, Swaroop C, Agarwala S, et al. Randomized control trial comparing oral moxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacina as outpatient therapy in peiatric low-risk febrile neutropenia. J Pediatr Hematol Oncol 2009;31:635-641.
11. Cagol AR, Galvao de Castro CJ, et al. Oral vs intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy. J Pediatr (Rio J) 2009;85:531-5.
12. Petrilli AS, Dantas LS, Campos MC, et al. Oral ciprofloxacin vs intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol 2000; 34:87-91.
13. de Naurois J, Novitzky-Basso I, Gill MJ, et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann of Oncol 2010;21:v252-6.
14. Scheinemann K, Ethier MC, Dupuis LL, et al. Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central lin. Support Care Cancer 2010; 18:913-9.
15. Kellogg J, Manzella J, Bankert D. Frequency of low level bacteremia in children from birth to fifteen years of age. J Clin Microbiol. 2000;38:2181-5.
16. Connell TG, Rele M, Cowley D, et al. How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatric 2007;119:891-6.
17. Riedel S, Bourbeau P, Swartz B, et al. Timing of specimen collection for blood cultures from febrile patients with Bacteremia. J Clin Microbiol 2008;46: 1381-5.
18. Penack O, Rempf P, Eisenblätter M, et al. Bloodstream infections in neutropenic patients: early detection of pathogen and directed antimicrobial therapy due to surveillance blood cultures. Ann Oncol 2007; 18:1870-4.